World's Best Scientists 2026 revealed!
Jean-Sébastien Hulot

Jean-Sébastien Hulot

D-Index & Metrics

Medicine

D-Index
85
Citations
32579
World Ranking
14452
National Ranking
464

Overview

Jean-Sébastien Hulot is affiliated with Inserm in France and has an extensive research portfolio primarily focused on medicine and biochemistry, genetics, and molecular biology. Their published work spans multiple subfields of study, notably cardiology and cardiovascular medicine, molecular biology, infectious diseases, surgery, and neurology.

Their research addresses a variety of topics including cardiovascular function and risk factors, COVID-19 clinical research studies, heart failure treatment and management, cardiac fibrosis and remodeling, cardiomyopathy and myosin studies, long-term effects of COVID-19, and cardiac electrophysiology and arrhythmias.

Some of the recent papers authored or co-authored by Jean-Sébastien Hulot include:

  • Statin therapy is associated with lower prevalence of gut microbiota dysbiosis, 2020, Nature
  • Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC), 2020, European Journal of Heart Failure
  • Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology, 2020, European Journal of Heart Failure
  • Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology, 2020, Nature Communications
  • Combinatorial, additive and dose-dependent drug-microbiome associations, 2021, Nature

Frequent co-authors collaborating with Jean-Sébastien Hulot include:

  • Charlène Jouve
  • Antoine Fayol
  • Magali Seguret
  • David Sassoon
  • Zeina R. Al Sayed

The scientist regularly publishes in the following venues:

  • Archives of Cardiovascular Diseases Supplements
  • bioRxiv (Cold Spring Harbor Laboratory)
  • European Heart Journal
  • Archives of cardiovascular diseases
  • European Journal of Heart Failure

Best Publications

  • 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

    Gilles Montalescot;Udo Sechtem;Stephan Achenbach;Felicita Andreotti

  • Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.

    Jessica L. Mega;Tabassome Simon;Jean Philippe Collet;Jeffrey L. Anderson

  • Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study

    Jean-Philippe Collet;Jean-Sébastien Hulot;Anna Pena;Eric Villard

  • Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects

    Jean-Sébastien Hulot;Alessandra Bura;Eric Villard;Michel Azizi

  • Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update

    Scott Sa;Sangkuhl K;Stein Cm;Hulot Js;Hulot Js

  • Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.

    Philippe Lechat;Jean-Sébastien Hulot;Sylvie Escolano;Alain Mallet

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450–2C19 (CYP2C19) Genotype and Clopidogrel Therapy

    SA Scott;K Sangkuhl;EE Gardner;CM Stein

  • Natural History and Risk Stratification of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

    Jean-Sébastien Hulot;Xavier Jouven;Jean-Philippe Empana;Robert Frank

  • Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration: A Systematic Meta-Analysis

    Jean Sébastien Hulot;Jean Philippe Collet;Johanne Silvain;Ana Pena

  • Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

    Sara Vieira-Silva;Gwen Falony;Eugeni Belda;Trine Nielsen

  • Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial

    Kim-Thanh Ong;Kim-Thanh Ong;Jerome Perdu;Julie De Backer;Erwan Bozec

  • Feasibility and safety of ultrasound-aided thoracentesis in mechanically ventilated patients.

    D. Lichtenstein;J.-S. Hulot;A. Rabiller;I. Tostivint

  • Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.

    Nathalie Costedoat-Chalumeau;Zahir Amoura;Jean-Sébastien Hulot;Hala Abou Hammoud

  • Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).

    Jelena Čelutkienė;Radek Pudil;Teresa López-Fernández;Julia Grapsa

  • Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy

    Hassane Izzedine;Jean-Sebastien Hulot;Eric Villard;Catherine Goyenvalle

  • Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies.

    Hassane Izzedine;Jean Sebastien Hulot;Vincent Launay-Vacher;Patrick Marcellini

  • Clinical, angiographic, and genetic factors associated with early coronary stent thrombosis.

    Guillaume Cayla;Jean-Sébastien Hulot;Stephen A. O’Connor;Atul Pathak

  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

    Pierre-Louis Tharaux;Gilles Pialoux;Arthur Pavot;Xavier Mariette

  • Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.

    Jean-Christophe Corvol;Anissa Bouzamondo;Marc Sirol;Jean-Sébastien Hulot

Frequent Co-Authors

Gilles Montalescot
Gilles Montalescot Baim Institute for Clinical Research
Roger J. Hajjar
Roger J. Hajjar Icahn School of Medicine at Mount Sinai
Jean-Philippe Collet
Jean-Philippe Collet Sorbonne University
Christian Funck-Brentano
Christian Funck-Brentano Université Paris Cité
Nathalie Costedoat-Chalumeau
Nathalie Costedoat-Chalumeau Université Paris Cité
Zahir Amoura
Zahir Amoura Université Paris Cité
Jean-Charles Piette
Jean-Charles Piette Sorbonne University
Ronald A. Li
Ronald A. Li University of Hong Kong
Patrice Cacoub
Patrice Cacoub Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens diverse alternative pathways in healthcare, especially for those seeking flexible or accelerated options. For individuals without a nursing background, cheapest direct entry msn programs offer an affordable route to earn a master's in nursing quickly and start working in advanced roles.

If entry barriers are a concern, consider nursing programs with high acceptance rates, which make it easier to launch a career in this in-demand field. Many aspiring healthcare professionals also pursue careers in medical administration. For those interested, medical billing and coding schools that accept financial aid provide reputable and accessible options.

Additionally, if standardized tests are a challenge, consider enrolling in an lpn school without teas test. These programs can help you enter the workforce sooner, expanding your opportunities in the growing healthcare sector.

Best Scientists Citing Jean-Sébastien Hulot

Trending Scientists

Recently Published Articles